Summary

Reforms in primary care likely to aid growth opportunities for medical devices in France

As of 2021, France has 1,293 public healthcare facilities, 1,280 private for-profit healthcare facilities, and 668 private non-profit facilities. With over 11% of its GDP allocated towards healthcare, the country has among the highest spent on this sector when compared to other European countries. In addition, France’s med-tech market is valued at about 20 billion Euros and is ranked 4th worldwide. France is well-equipped with healthcare professionals, having over 220,000 doctors throughout the country. However, as observed in the recent years, there has been a growing discontent among the French healthcare system due to staff burnout, reduction in number of beds and general overcrowding of hospitals especially across emergency care facilities.

According to EMeRG’s new HospeTrack Hospital Intelligence for France, the hospital-focused healthcare system is expected to gradually start sharing its load with the primary care sector. It is likely that telemedicine will form the fabric of interconnectivity between primary care and the higher referral facilities. Reform announcements as part of the Ma Santé 2022 law are likely to ensure 500-600 clinics being renamed as local / nearby hospitals. While this might lead to consolidation of specialized services such as maternity care of surgical services; opportunities across general medicine and geriatric care are likely to increase. In addition, government initiatives will continue to be targeted towards expansion of public healthcare and maximum patient outreach. Such initiatives may include addition of 4,000 medical assistants by 2022; and incorporation of 300 more regional multidisciplinary healthcare centers to offer various primary care services within a single premise. As noted recently, 7 billion Euros have been earmarked towards improving the public healthcare sector by the French government. The country is also likely to invest 2 billion euros in research for emerging and infectious diseases, as well as digital health.

The ongoing impetus around improving the usage of telemedicine is likely to create an ecosystem for growth of digital technologies in France. With the new law offering provisions for nurses to offer telecare while encouraging the formation of digital health space for all patients, opportunities for several healthcare-IT solutions are likely to increase. Despite telemedicine being used only by about 2,000 physicians as of early 2020, the overall telemedicine consultations have been on the rise. The upward trend is likely to continue as favorable reimbursement of teleconsultations is enabled.

Increased investment by corporate entities in the healthcare sector is likely to be seen in the next few years. For instance, a major corporate chain is planning to invest 1 billion Euros in the French healthcare real estate sector by 2022. Several private investments might continue in specializations such as interventional cardiology where the demand for percutaneous coronary interventions has been significant. As per the HospeTrack dataset, there are over 400 cath labs in France. Every year, patients in France undergo specialized procedures enabling implantation of 1,200 thoracic aortic stent grafts, 7,000 abdominal aortic stent grafts, 15,000 implantable cardioverter-defibrillators, and 25,000 heart valves. With the country gradually emerging as a world leader in selling medical technologies that use X-ray, MRI, or light-wave methods, sales opportunities for medical imaging and interventional technologies are likely to remain stable.

The report provides account-level directional detail on total beds, ICU beds, ORs, ventilators, incubators, and other medical equipment installed in France as well as Anesthesia Machines, Dialysis machines, C-Arms, Cath Labs, PET, SPECT, CT, MRI scanners, Ultrasound, and X-Ray machines and Mammography machines, making it a noteworthy source of hospital-level intelligence for France’s medical equipment installed base.

The report is a skillfully designed dataset that is an invaluable resource for any organization in the process of optimizing sales targets, estimating market potential, or developing an account management strategy in France. It provides a graphical overview of the country’s health infrastructure, as well as an account-level view of resources, directional information on the medical device installed base, hospital demographics, and care services.

Key companies included in the dataset: Drager, Mindray, GE Healthcare, B Braun, Baxter, Gambro, Nikkiso, Fresenius Medical Care, Philips Healthcare, Siemens Healthcare, Ziehm Imaging, Medtronic, Toshiba Medical Systems, Canon Medical Systems, Spectrum Dynamics, Hitachi Medical Systems, Mridian, Esaote, Fujifilm Medical Systems, Samsung Healthcare, SIUI, Sonosite, Carestream, GMM, Primax, Stephanix, Hologic, IMS Giotto, Planmed